Recent Updates
Recently added Catalysts
BBIO

Eidos Therapeutics To Present Phase 2 Data For AG10 In TTR Amyloidosis Cardiomyopathy At The AHA 2018 Scientific Sessions In A Late-breaking Featured Science Oral Presentation

Friday, October 5, 2018 1 min read
Key Takeaway: Eidos Therapeutics To Present Phase 2 Data For AG10 In TTR Amyloidosis Cardiomyopathy At The AHA 2018 Scientific Sessions In A Late-breaking Featured Science Oral Presentation

Full Press Release Details

Eidos Therapeutics To Present Phase 2 Data For AG10 In TTR Amyloidosis Cardiomyopathy At The AHA 2018 Scientific Sessions In A Late-breaking Featured Science Oral Presentation.
Tags: BBIO Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Oct 5, 2018